Cardiovascular Drugs Practice Questions

Q: In which of the following conditions are beta-blockers contraindicated?

Acute congestive heart failure. ### Explanation **Correct Option: A. Acute Congestive Heart Failure (CHF)** Beta-blockers are contraindicated in **Acute CHF** because they possess **negative inotropic** properties. In an acute decompensated state, the heart relies on sympathetic stimulation (increased heart rate and contractility) to maintain cardiac output. Administering a beta-blocker at this stage can further depress myocardial contractility, leading to a rapid decline in cardiac output, worsening pulmonary edema, and potential cardiogenic shock. **Analysis of Incorrect Options:** * **B. Hypertension:** Beta-blockers (like Atenolol or Metoprolol) are used as second-line agents in hypertension, especially in patients with co-morbidities like post-MI or stable angina. * **C. Chronic CHF:** While contraindicated in *acute* failure, beta-blockers (specifically **Bisoprolol, Carvedilol, and Metoprolol succinate**) are the gold standard for *stable, chronic* heart failure. They prevent cardiac remodeling and reduce mortality by protecting the heart from chronic catecholamine toxicity. * **D. Arrhythmia:** Beta-blockers are Class II anti-arrhythmics. They are the drugs of choice for controlling ventricular rate in atrial fibrillation and managing supraventricular tachycardias (SVT). **High-Yield NEET-PG Pearls:** 1. **The "ABC" of Beta-blockers in Chronic CHF:** Only three are proven to reduce mortality: **A**tenolol is NOT one of them; they are **B**isoprolol, **C**arvedilol, and **M**etoprolol succinate. 2. **Other Absolute Contraindications:** Severe Bradycardia, 2nd or 3rd-degree Heart Block, and **Prinzmetal (Variant) Angina** (due to unopposed alpha-mediated vasoconstriction). 3. **Asthma/COPD:** Non-selective beta-blockers (e.g., Propranolol) are contraindicated due to bronchospasm risk. Use cardioselective ($\beta_1$) blockers if necessary.

Q: Which of the following drugs is contraindicated in bilateral renal artery stenosis?

Enalapril. **Explanation:** **Correct Option: B. Enalapril** Enalapril is an ACE inhibitor (ACEi). In patients with **bilateral renal artery stenosis (RAS)**, the renal perfusion pressure is significantly reduced. To maintain an adequate Glomerular Filtration Rate (GFR), the kidney relies on the renin-angiotensin-aldosterone system (RAAS). Specifically, **Angiotensin II** causes preferential **vasoconstriction of the efferent arteriole**, which builds up the intraglomerular pressure necessary for filtration. When an ACE inhibitor like Enalapril is administered, it inhibits the production of Angiotensin II, leading to efferent arteriolar vasodilation. This causes a precipitous drop in intraglomerular pressure, resulting in **acute renal failure**. Therefore, ACE inhibitors and ARBs are strictly contraindicated in bilateral RAS (or unilateral RAS in a solitary functioning kidney). **Incorrect Options:** * **A. Hydralazine:** A direct vasodilator primarily used in pregnancy-induced hypertension. It does not interfere with the RAAS-mediated autoregulation of GFR. * **C. Methyldopa:** A centrally acting alpha-2 agonist. It is safe for renal hemodynamics and is a preferred drug in pregnancy. * **D. Dopamine:** At low doses, dopamine causes renal vasodilation (via D1 receptors) and generally increases renal blood flow, rather than causing a drop in GFR. **High-Yield Clinical Pearls for NEET-PG:** * **Diagnostic Clue:** Suspect bilateral RAS if a patient’s serum creatinine rises by **>30%** after starting an ACE inhibitor or ARB. * **Drug of Choice:** Calcium Channel Blockers (CCBs) are generally considered safe for managing hypertension in patients with bilateral RAS. * **Auscultation:** The presence of an abdominal bruit is a classic clinical sign of renal artery stenosis.

Q: Which of the following statements about Ivabradine is FALSE?

It causes tachycardia.. **Explanation:** **Ivabradine** is a unique heart-rate-lowering agent. The correct answer is **C**, as Ivabradine causes **bradycardia**, not tachycardia. 1. **Why Option C is False:** Ivabradine selectively inhibits the **$I_f$ (funny) current** in the sinoatrial (SA) node. This current is responsible for the spontaneous diastolic depolarization that determines heart rate. By blocking these channels, Ivabradine slows the firing rate of the SA node, leading to a reduction in heart rate (**bradycardia**). It is specifically used when a patient cannot tolerate beta-blockers or when the heart rate remains >70 bpm despite optimal therapy. 2. **Analysis of Other Options:** * **Option A:** This is **true**. Ivabradine is a pure $I_f$ channel blocker. * **Option B:** This is **true**. By reducing the heart rate, it decreases myocardial oxygen demand without affecting contractility or blood pressure, making it effective for the **prophylaxis of stable angina**. * **Option D:** This is **true**. $I_f$ channels are structurally similar to **$I_h$ channels** in the retina. Inhibition of these retinal channels can cause transient luminous phenomena (phosphenes) or blurred vision, which are characteristic side effects. **High-Yield Clinical Pearls for NEET-PG:** * **Indication:** Stable Angina and Chronic Heart Failure (NYHA Class II-IV) with EF ≤35%. * **Requirement:** The patient must be in **Sinus Rhythm** for the drug to work (it is ineffective in Atrial Fibrillation). * **Benefit:** Unlike beta-blockers, it has no effect on ventricular repolarization, myocardial contractility, or airway resistance (safe in asthma). * **Side Effects:** Bradycardia, Phosphenes (visual brightness), and Hypertension.

Q: Which of the following drugs should be avoided in a pregnant female with dilated cardiomyopathy?

ACE inhibitors. **Explanation:** **ACE inhibitors (ACEIs)** are strictly contraindicated in pregnancy (Category D) due to their significant **teratogenic potential**. While they are first-line agents for dilated cardiomyopathy (DCM) in non-pregnant patients, they must be avoided during pregnancy. Their use, particularly in the second and third trimesters, leads to **fetal renal dysgenesis**, which causes oligohydramnios. This lack of amniotic fluid results in the "Potter sequence" (pulmonary hypoplasia, limb deformities, and cranial facial abnormalities) and fetal skull hypoplasia. **Analysis of Incorrect Options:** * **Beta-blockers:** These are generally considered safe and are often used to manage DCM and arrhythmias in pregnancy. While they may be associated with fetal growth restriction (IUGR) or neonatal hypoglycemia, they are not contraindicated. * **Digoxin:** It is considered safe during pregnancy (Category C) and is the drug of choice for controlling ventricular rate in pregnant patients with heart failure or atrial fibrillation. * **Calcium Channel Blockers (CCBs):** While not first-line for DCM, drugs like Nifedipine are frequently used in pregnancy for hypertension or as tocolytics and are not teratogenic. **High-Yield Clinical Pearls for NEET-PG:** * **Management of DCM in Pregnancy:** The preferred regimen includes **Hydralazine and Nitrates** (as a substitute for ACEIs/ARBs), along with **Digoxin** and **Diuretics** (used cautiously). * **ACEI Fetopathy:** Characterized by renal failure, hypotension, and skull hypoplasia. * **Other Contraindicated Drugs in Pregnancy:** Warfarin (Fetal Warfarin Syndrome), Phenytoin (Fetal Hydantoin Syndrome), Tetracyclines (discolored teeth), and Isotretinoin (severe craniofacial defects).

Q: Clevidipine is a type of which drug class?

Calcium Channel Blocker. **Clevidipine** is a third-generation, ultra-short-acting **Dihydropyridine (DHP) Calcium Channel Blocker (CCB)** [1, 2]. It works by inhibiting the L-type calcium channels in vascular smooth muscle, leading to potent peripheral vasodilation and a rapid reduction in blood pressure without affecting myocardial contractility or venous capacitance [1].**Why the other options are incorrect:** * **ACE Inhibitors (e.g., Enalapril):** These inhibit the conversion of Angiotensin I to Angiotensin II. They are characterized by the suffix "-pril" and are not chemically related to DHPs.* **Alpha Blockers (e.g., Prazosin):** These block alpha_1-adrenergic receptors to cause vasodilation [2]. They do not act on calcium channels.* **ARBs (e.g., Telmisartan):** These block the AT_1 receptor directly. They are characterized by the suffix "-sartan."**High-Yield Clinical Pearls for NEET-PG:** * **Pharmacokinetics:** Clevidipine is unique because it is metabolized by **blood and tissue esterases**, making its clearance independent of renal or hepatic function.* **Half-life:** It has an extremely short half-life (approx. **1 minute**), allowing for rapid titration and quick offset of action.* **Clinical Use:** It is primarily used for the management of **Hypertensive Emergencies** and perioperative blood pressure control.* **Formulation:** It is administered as a **lipid emulsion** (similar to Propofol); therefore, it is contraindicated in patients with severe disorders of lipid metabolism (e.g., pathological hyperlipidemia) or allergies to soy/eggs.

Q: All of the following drugs can worsen angina, except:

Oxyphedrine. **Explanation:** The core concept behind this question is the **"Coronary Steal Phenomenon"** and the myocardial oxygen supply-demand balance. **Why Oxyphedrine is the correct answer:** Oxyphedrine is a unique drug used in the treatment of angina. It acts as a **partial beta-agonist** and has a direct metabolic effect on the myocardium. Unlike potent vasodilators, it improves myocardial metabolism and increases coronary blood flow without causing "coronary steal." Therefore, it is used to *treat* angina rather than worsen it. **Why the other options are incorrect:** * **Dipyridamole:** This is a potent arteriolar dilator. In patients with coronary artery disease, it dilates healthy vessels, "stealing" blood flow away from the already maximally dilated, ischemic distal vessels (the **Coronary Steal Phenomenon**). This worsens ischemia. * **Thyroxine:** It increases the metabolic rate and upregulates beta-receptors in the heart. This leads to increased heart rate and contractility, significantly raising **myocardial oxygen demand**, which can precipitate an anginal attack. * **Sumatriptan:** As a 5-HT$_{1B/1D}$ agonist used for migraines, it can cause **coronary vasospasm**. It is strictly contraindicated in patients with known ischemic heart disease (Prinzmetal or stable angina). **High-Yield NEET-PG Pearls:** * **Coronary Steal Phenomenon:** Classically associated with Dipyridamole and Hydralazine. * **Drugs causing Vasospasm:** Sumatriptan, Ergotamine, and Cocaine. * **Oxyphedrine:** Often classified as a "myocardial enhancer" or "coronary dilator" that is safe in chronic stable angina. * **Thyrotoxicosis:** Always consider it as a secondary cause of worsening angina or new-onset Atrial Fibrillation in elderly patients.

Q: All of the following statements about Ranolazine are true, except?

Hypotension is an established adverse effect.. **Explanation:** **Ranolazine** is a novel antianginal agent with a unique mechanism of action. The correct answer is **D** because, unlike traditional antianginals (Nitrates, Beta-blockers, CCBs), **Ranolazine does not significantly affect heart rate or blood pressure.** Therefore, hypotension is not an established adverse effect. **Breakdown of Options:** * **Option A (True):** Ranolazine is chemically a **piperazine derivative**. It works by inhibiting the **late inward sodium current ($I_{Na}$)** in myocardial cells. This prevents calcium overload via the $Na^+/Ca^{2+}$ exchanger, improving diastolic relaxation and subendocardial perfusion without altering hemodynamics. * **Option B (True):** According to recent guidelines, Ranolazine is approved as a **first-line agent** for chronic stable angina, either as monotherapy or in combination with other drugs. * **Option C (True):** Clinical trials (like CARISA and MERLIN-TIMI 36) have shown that Ranolazine can **reduce HbA1c levels** in diabetic patients, making it a preferred choice for anginal patients with comorbid Diabetes Mellitus. **High-Yield Clinical Pearls for NEET-PG:** * **ECG Change:** Ranolazine causes **dose-dependent QT interval prolongation** (via inhibition of $I_{Kr}$), yet it paradoxically has a low risk of Torsades de Pointes. * **Metabolism:** It is primarily metabolized by **CYP3A4**; hence, it is contraindicated with potent inhibitors like Ketoconazole or Clarithromycin. * **Side Effects:** Most common side effects include dizziness, headache, constipation, and nausea. * **Key Benefit:** It is the drug of choice for angina patients who have low baseline blood pressure or heart rate, as it does not lower them further.

Question 1

In which of the following conditions are beta-blockers contraindicated?

Accepted Answer

Acute congestive heart failure

Answer

Hypertension

Answer

Chronic congestive heart failure

Answer

Arrhythmia

Question 2

Which of the following drugs is contraindicated in bilateral renal artery stenosis?

Accepted Answer

Enalapril

Answer

Hydralazine

Answer

Methyldopa

Answer

Dopamine

Question 3

Which of the following statements about Ivabradine is FALSE?

Accepted Answer

It causes tachycardia.

Answer

It acts by inhibiting the funny current (If).

Answer

It is used in the long-term prophylaxis of stable angina.

Answer

It may lead to visual field defects.

Question 4

What is the antihypertensive of choice for a patient with hypertension, diabetes mellitus, and proteinuria?

Accepted Answer

Alpha-methyldopa

Answer

Propranolol

Answer

Clonidine

Answer

Enalapril

Question 5

Which of the following drugs should be avoided in a pregnant female with dilated cardiomyopathy?

Accepted Answer

ACE inhibitors

Answer

Beta blockers

Answer

Digoxin

Answer

Calcium channel blockers

Question 6

Clevidipine is a type of which drug class?

Accepted Answer

Calcium Channel Blocker

Answer

Angiotensin-Converting Enzyme Inhibitor (ACEI)

Answer

Alpha Blocker

Answer

Angiotensin Receptor Blocker (ARB)

Question 7

All of the following drugs can worsen angina, except:

Accepted Answer

Oxyphedrine

Answer

Dipyridamole

Answer

Thyroxine

Answer

Sumatriptan

Question 8

Septicemic shock with multi-organ failure is treated by which of the following medications?

Accepted Answer

Norepinephrine

Answer

Adrenaline

Answer

Ephedrine

Answer

Phenylephrine

Question 9

All of the following statements about Ranolazine are true, except?

Accepted Answer

Hypotension is an established adverse effect.

Answer

Piperazine derived antianginal agent.

Answer

May be used as first line agent in chronic angina.

Answer

May improve glycemic control.

Question 10

Which drug is contraindicated in severe hypertriglyceridemia?

Accepted Answer

Niacin

Answer

Fibrates

Answer

Simvastatin

Answer

Cholestyramine

Cardiovascular Drugs — MCQs

Cardiovascular Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?